Editas Medicine, Inc.
EDIT
$2.22
-$0.13-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -84.78% | 50,070.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -84.78% | 50,070.49% | |||
| Cost of Revenue | -98.13% | 2.04% | |||
| Gross Profit | 120.83% | 62.15% | |||
| SG&A Expenses | -18.22% | -9.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -38.48% | -1.16% | |||
| Operating Income | -2.76% | 47.67% | |||
| Income Before Tax | -67.61% | 26.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -67.61% | 26.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -67.61% | 26.95% | |||
| EBIT | -2.76% | 47.67% | |||
| EBITDA | -1.25% | 48.52% | |||
| EPS Basic | -66.72% | 27.06% | |||
| Normalized Basic EPS | -5.66% | 46.71% | |||
| EPS Diluted | -66.72% | 27.06% | |||
| Normalized Diluted EPS | -5.66% | 46.71% | |||
| Average Basic Shares Outstanding | 0.53% | 0.16% | |||
| Average Diluted Shares Outstanding | 0.53% | 0.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||